465 results about "Pelvic inflammatory disease" patented technology

A novel method for detection of an inflammatory disease and a novel composition for prevention or treatment of an inflammatory disease are provided. The method for detection of an inflammatory disease comprises using RANKL and / or OPG as a marker in a biological sample. The composition for prevention or treatment of an inflammatory disease comprises RANKL and / or M-CSF as an active ingredient.

Compounds of formula (I):wherein R1, R2, J, Q, V, X, Y and Z are defined herein are disclosed. The compounds are inhibitors of the family of p38 mitogen-activated protein kinase enzymes (referred to herein as p38 MAP kinase inhibitors), particularly the alpha sub-type thereof, and of Syk kinase and the Src family of tyrosine kinases. The compounds may be used in therapy, including in pharmaceutical combinations, especially in the treatment of inflammatory diseases, in particular inflammatory diseases of the lung, such as asthma and COPD, as well as those of the gastrointestinal tract, such as ulcerative colitis and Crohn's disease and of the eye, such as uveitis.

An anti-inflammatory and staltic medicine for treating gynopathy, especially the chronic pelvic inflammation is prepared from paris polyphylla through crushing, soaking, filtering, extracting, concentrating, drying, pulverizing, etc.

A method and system for targeting the microbiome to promote health involves exposing an expectant mother to a mixture of farm derived manure-containing soil to reduce the chances her baby will suffer allergies and autoimmune diseases. City dwelling expectant mothers are exposed to immunologic agents and allergens in a fashion (e.g., via exposure to farm animal manure-containing soils) that charges their immune system and that of their fetus(es) so that their babies, once born, are provided with immunity against a variety of autoimmune diseases, including allergies commonly and increasingly experienced in modern urban environments.

This invention relates to the diagnosis and / or monitoring of patients with inflammatory diseases or conditions, including systemic lupus erythematosus, particularly for diagnosis of the acute stage of the disease, including methods and kits for carrying out this activity. This disclosure presents the surprising discovery that levels of complement pathway components on reticulocytes can be used to diagnose, monitor, or predict the occurrence of acute episodes of chronic inflammatory diseases or conditions.

The invention discloses an oral Chinese medicinal composition for treating pelvic inflammatory disease and belongs to a Chinese medicinal preparation. The oral Chinese medicinal composition is prepared from the following raw material medicaments by weight: 25 grams of honeysuckle flower, 25 grams of dandelion, 25 grams of patrinia scabiosaefolia, 20 grams of amur corktree bark, 20 grams of red paeony root, 20 grams of astragalus, 15 grams of raw rehmannia root, 15 grams of bupleurum, 15 grams of root of red-rooted salvia, 15 grams of Chinese angelica, 15 grams of Indian buead, 10 grams of peach seed, 10 grams of dragon's blood, 10 grams of largehead atractylodes rhizome, 10 grams of dogwood, 10 grams of immature bitter orange, 10 grams of zedoary, 10 grams of twotooth achyranthes root, 10 grams of nutgrass galingale rhizome and 3 grams of liquoric root. The oral Chinese medicinal composition has the effects of clearing heat and detoxicating, activating blood and dissolving stasis, regulating vital energy and clearing damp and inducing menstruation to relieve menalgia and has the advantages of quick response, short treatment period, simple treatment method, low cost, no side effects on a human body, no adverse effects on health of a patient and the like in the aspect of treating the pelvic inflammatory disease.

The invention relates to Chinese medicinal gel for treating gynecological inflammation and a preparation method thereof. The Chinese medicinal gel comprises the following raw material medicaments in part by weight: 270 to 330 parts of sophora flavescens, 250 to 275 parts of Chinese pulsatilla root, 45 to 55 parts of catecholamine, 225 to 275 parts of dandelion, 225 to 275 parts of cortex dictamni, 270 to 330 parts of fructus cnidii, 270 to 330 parts of belvedere fruit, 225 to 275 parts of phellodendron amurense and 225 to 275 parts of sessile stemona root. Each raw material medicament in the Chinese medicinal gel disclosed by the invention has the effects of clearing heat, removing toxicity, dispersing swelling, removing stasis and killing parasites to relieve itching; and the Chinese medicinal gel can be used for treating gynecological diseases such as the vaginitis, the pelvic inflammatory disease, the cervicitis, the cervical erosion and the like.

The invention discloses an oral administration pharmaceutical composition for treating chronic pelvic inflammatory disease, wherein the active constituents include the following raw material herbs (by weight portion): honeysuckle flower 20g, capsule of weeping forsythia 10g, hooked uncaria 20g, spatholobus stem 10g, herba patriniae 10g, coix seed 10g, root bark of tree peony 6g, cape jasmine 12g, red peony root 2g, peach kernel 12g, corydalis tuber 9g, toosendan fruit 9g, frankincense 4.5g, myrrh 4.5g, rhizome of Sichuan lovage 6g, motherwort 10g, flavescent sophora root 10g. The medicament should be decocted in water for the oral dose.